Reduning Injection versus Neuraminidase Inhibitors in the Treatment of Influenza: A Systematic Review and Meta-Analysis
Back to article page
|Updated:2022-05-13
|
Reduning Injection versus Neuraminidase Inhibitors in the Treatment of Influenza: A Systematic Review and Meta-Analysis
Chinese Journal of Integrative MedicinePages: 1-9
Affiliations:
Author bio:
Funds:
Supported by the National Major Science and Technology Project of China (No. 2017ZX10305501) and the Beijing Municipal Hospital Scientific Research Cultivation Program (No. PZ2020016),Availability of Data and Materials,The datasets analyzed in this study are supported by the published articles in opening electronic databases (details in search strategy).,Conflict of Interest,All authors have completed the International Committee of Medical Journal Editors (ICMJE) uniform disclosure form. The authors have no conflicts of interest to declare.,Author Contributions,Conception and design: Zhao GZ, Li B and Liu QQ; administrative support: Guo YH and Liu QQ; Provision of study materials or patients: Zhao GZ and Ma QX; collection and assembly of data: Wang YF and Guo SQ; data analysis and interpretation: Zhao GZ and Du Y; Manuscript writing: Zhao GZ; final approval of manuscript: All authors.
Guo-zhen Zhao, Bo Li, Ya-fan Wang, et al. Reduning Injection versus Neuraminidase Inhibitors in the Treatment of Influenza: A Systematic Review and Meta-Analysis. [J/OL]. 1-9(0)
DOI:
Guo-zhen Zhao, Bo Li, Ya-fan Wang, et al. Reduning Injection versus Neuraminidase Inhibitors in the Treatment of Influenza: A Systematic Review and Meta-Analysis. [J/OL]. 1-9(0) DOI: 10.1007/s11655-022-3524-9.
Reduning Injection versus Neuraminidase Inhibitors in the Treatment of Influenza: A Systematic Review and Meta-Analysis
Effectiveness and Safety of Chinese Medicine at Shenque (CV 8) for Primary Dysmenorrhea: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Related Author
No data
Related Institution
Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China;Department of Oncology, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, China;Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK;Research Design Service South Central, National Institute of Health Research, Southampton, UK;School of Nursing, Beijing University of Chinese Medicine, Beijing, China;Department of Nursing, Beijing Friendship Hospital, Beijing, China;Institute of Health and Social Care, London South Bank University, London, UK